DOBROCAM
- Registration number:ЛП 000141
- International non-proprietary name:bromocamphor
- Pharmaceutical form:tablets
- Pharmacotherapeutic group:sedating medication
- Dosage form:tablets 250 mg No. 30
- Composition:bromocamphor - 250 mg
DOBROCAM is a sedating medication, bromine preparation. Along with other bromides, it can enhance the inhibitory processes in the brain cortex, especially in case of increased excitability of central nervous system. It facilitates natural sleep to begin.
- Indications for use:
-
- increased nervous irritability;
- neurasthenia;
- cardialgia, tachycardia;
- labile blood pressure;
- sleep disorder.
- Method of administration and posology:
-
For oral administration, after meal.
- For adults and children over 14 years old:
1-2 tablets 2-3 times daily;
Maximal daily dose: for adults and children over 14 years old - 1.5 g.
- For adults and children over 14 years old:
-
- For children:
— 7–10 years old — 1 tablet 2 times daily;
Maximal daily dose for children aged 7–10 years — 0.5 g.
— 10–14 years old — 1 tablet 2–3 times daily;
Maximal daily dose for children aged 10–14 years — 0.75 g.Treatment course is 10-15 days.
- For children:
- Shelf life:
-
5 years. Do not use after the expiry date.
- Manufacturer
- OJSC "Irbitsky Chemical-Pharmaceutical Plant"
We recommend
-
-
Antimicrobial agent
-
Enzyme product
-
-
Vitamin preparation
-
Antimicrobial agent
-
Calcium channel blocker
-
NOBAZIT®
-
Metabolic agent
-
Antimicrobial agent
-
antiviral agent, aciclovir
-
Antifungal agents
-
Combination drug
-
Antifungal agent
-
Non-steroidal anti-inflammatory drug (NSAID)
-
Coronary dilating drug
-
Antimicrobial and antiprotozoal agent
-
Antifungal agent
-
Antimicrobial agent
-
-
Antimicrobial and antiprotozoal agent.
-
Enterosorbent.
-
-
Antimicrobial agent
-
Antiepileptic agent
-
Antiviral drug
-
Combination antimicrobial agent
-
Spasmolytic agent
-
-
Sedating medication
-
Combination drug
-
-
Analgesic agent
-
-
Potassium and magnesium preparation